Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Titel:
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
Auteur:
Machiels, Jean-Pascal H Haddad, Robert I Fayette, Jérôme Licitra, Lisa F Tahara, Makoto Vermorken, Jan B Clement, Paul M Gauler, Thomas Cupissol, Didier Grau, Juan José Guigay, Joël Caponigro, Francesco de Castro Jr, Gilberto de Souza Viana, Luciano Keilholz, Ulrich del Campo, Joseph M Cong, Xiuyu Julie Ehrnrooth, Eva Cohen, Ezra E W